THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY
The best methods of identification of the financial assets and liabilities with highest risk concentration on the example of pharmaceutical companies have been considered. It is well known, that significant risks are subject to disclosure in financial statements of organization, because they can inf...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | RU |
Publicado: |
Publishing House of the State University of Management
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e785eea84cd64a1ab7ddf7449881eeb0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:e785eea84cd64a1ab7ddf7449881eeb0 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:e785eea84cd64a1ab7ddf7449881eeb02021-12-03T07:43:29ZTHE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY1816-42772686-841510.26425/1816-4277-2019-6-134-142https://doaj.org/article/e785eea84cd64a1ab7ddf7449881eeb02019-06-01T00:00:00Zhttps://vestnik.guu.ru/jour/article/view/1520https://doaj.org/toc/1816-4277https://doaj.org/toc/2686-8415The best methods of identification of the financial assets and liabilities with highest risk concentration on the example of pharmaceutical companies have been considered. It is well known, that significant risks are subject to disclosure in financial statements of organization, because they can influence management decisions. It is important for professionals to understand how to correctly identify and assess the risks, influencing the financial statements, as well as to form a list of assets and liabilities, that are more affected by them. The above questions can be answered by the approaches presented in the article to the identification, assessment and systematization of risks, their impact on the financial statements, as well as the conclusions, formulated by the authors as a result of the research.O. AgeevaA. YolkinaPublishing House of the State University of Managementarticlerisk identificationfinancial statementsrisk mapinternal control and audit systemreflection of informationpharmaceutical industrySociology (General)HM401-1281Economics as a scienceHB71-74RUВестник университета, Vol 0, Iss 6, Pp 134-142 (2019) |
institution |
DOAJ |
collection |
DOAJ |
language |
RU |
topic |
risk identification financial statements risk map internal control and audit system reflection of information pharmaceutical industry Sociology (General) HM401-1281 Economics as a science HB71-74 |
spellingShingle |
risk identification financial statements risk map internal control and audit system reflection of information pharmaceutical industry Sociology (General) HM401-1281 Economics as a science HB71-74 O. Ageeva A. Yolkina THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY |
description |
The best methods of identification of the financial assets and liabilities with highest risk concentration on the example of pharmaceutical companies have been considered. It is well known, that significant risks are subject to disclosure in financial statements of organization, because they can influence management decisions. It is important for professionals to understand how to correctly identify and assess the risks, influencing the financial statements, as well as to form a list of assets and liabilities, that are more affected by them. The above questions can be answered by the approaches presented in the article to the identification, assessment and systematization of risks, their impact on the financial statements, as well as the conclusions, formulated by the authors as a result of the research. |
format |
article |
author |
O. Ageeva A. Yolkina |
author_facet |
O. Ageeva A. Yolkina |
author_sort |
O. Ageeva |
title |
THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY |
title_short |
THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY |
title_full |
THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY |
title_fullStr |
THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY |
title_full_unstemmed |
THE IDENTIFICATION AND SYSTEMATIZATION OF FINANCIAL ASSETS AND LIABILITIES, EXPOSED TO FINANCIAL RISKS, ON THE EXAMPLE OF THE PHARMACEUTICAL INDUSTRY |
title_sort |
identification and systematization of financial assets and liabilities, exposed to financial risks, on the example of the pharmaceutical industry |
publisher |
Publishing House of the State University of Management |
publishDate |
2019 |
url |
https://doaj.org/article/e785eea84cd64a1ab7ddf7449881eeb0 |
work_keys_str_mv |
AT oageeva theidentificationandsystematizationoffinancialassetsandliabilitiesexposedtofinancialrisksontheexampleofthepharmaceuticalindustry AT ayolkina theidentificationandsystematizationoffinancialassetsandliabilitiesexposedtofinancialrisksontheexampleofthepharmaceuticalindustry AT oageeva identificationandsystematizationoffinancialassetsandliabilitiesexposedtofinancialrisksontheexampleofthepharmaceuticalindustry AT ayolkina identificationandsystematizationoffinancialassetsandliabilitiesexposedtofinancialrisksontheexampleofthepharmaceuticalindustry |
_version_ |
1718373544911437824 |